Related Experiment Videos
Antihypertensive treatment in elderly hypertensives: implications of the MEHP study
1Department of Clinical Physiology, Sahlgrenska Hospital, University of Göteborg, Sweden.
Insights
Initiating antihypertensive treatment with beta-blockers, like metoprolol, offers better prevention of cardiovascular events and mortality compared to diuretics, especially in elderly patients.
Area of Science:
- Cardiology
- Gerontology
- Pharmacology
Background:
- Antihypertensive therapy is crucial for reducing cardiovascular and all-cause mortality.
- Diuretics have been a traditional first-line treatment for hypertension.
- Beta-blockers have shown promise in preventing cardiovascular complications.
Purpose of the Study:
- To compare the preventive effects of initiating antihypertensive treatment with beta-blockers versus diuretics.
- To evaluate the efficacy, safety, and tolerability of metoprolol in elderly hypertensive patients.
Main Methods:
- Analysis of secondary and primary preventive trials.
- Inclusion of results from the large-scale multicenter international MEHP study.
- Focus on elderly hypertensive patients receiving 100 mg metoprolol once daily.
Main Results:
- Beta-blocker initiation demonstrates superior preventive effects on total mortality, cardiovascular mortality, and atherosclerotic complications compared to diuretics.
- Metoprolol (100 mg once daily) proved effective, safe, and well-tolerated in elderly hypertensive individuals.
- Age-related increase in cardiovascular mortality and atherosclerotic complications highlights the importance of effective treatment.
Conclusions:
- Initiating antihypertensive treatment with beta-blockers is recommended over diuretics for better long-term cardiovascular outcomes.
- Metoprolol is a suitable and effective first-line antihypertensive agent for the elderly population.
- Effective management of hypertension in aging individuals is critical to mitigate age-associated cardiovascular risks.
Abstract:
Present evidence from several secondary and primary preventive trials indicates that if antihypertensive treatment is initiated with a beta-blocker, a better preventive effect on total mortality, cardiovascular mortality, and atherosclerotic complications can be expected than if diuretics are used as initial therapy. Results from a recent large-scale multicenter international study (MEHP) have shown that a regimen initiating antihypertensive treatment with 100 mg metoprolol once daily is effective, safe, and well-tolerated in elderly hypertensive patients. This might be of particular importance since a steep increase in cardiovascular mortality and other atherosclerotic complications is seen with age.